The fi rst full annual inventory of Maryland's forests reports approximately 2.5 million acres of forest land, which covers 40 percent of the State's land area and with a total volume of more than 2,100 cubic feet per acre. Nineteen percent of the growing-stock volume is yellow-poplar, followed by red maple (13 percent) and loblolly pine (10 percent). All species of oaks combined account for 26 percent of the total growing-stock volume. Yellow-poplar volume is increasing, particularly in the large-diameter classes. Red maple is the most abundant species in terms of number of trees and the population had been rising through the 1980s and 1990s, but current data show little change in red maple abundance since 1999. Seventy-six percent of forest land consists of large diameter, 14 percent contains medium diameter, and the remainder is in small diameter stand size classes or nonstocked stands. There were approximately 5.9 billion cubic feet of growing-stock volume in 2008, and the average annual growth rate of volume has been approximately 2 percent. Additional information on forest attributes, land-use change, carbon, timber products, and forest health is presented in this report. A DVD included in the report provides information on sampling techniques, estimation procedures, tables of population estimates, raw data, a data summarization tool, and a glossary.
AcknowledgmentsThe authors would like to thank the many individuals who contributed both to the inventory and analysis of
Most SCCHN patients are referred to community medical oncologists by primary care physicians or surgeons; it was estimated that two-thirds of presenting patients are newly diagnosed and that one-third have relapsed. None of the participants routinely test, document, or alter treatment for suspected HPV etiology. HPV positivity is clinically suspected based on a limited smoking and alcohol consumption history, younger age, good performance status, and locally advanced disease. Concurrent platinum-based chemoradiotherapy is standard of care for most patients with < 10% undergoing subsequent surgery. Ancillary services (dental work, central line placement, triple endoscopy, percutaneous endoscopic gastrostomy) do not impede chemotherapy initiation. Positron emission tomography (PET) is the standard for staging with restaging PET performed 3 months after last radiation dose. IO availability appears to have resulted in eliminating the need for a repeat PET at 6-months if a 3-month PET is positive allowing patients to initiate treatment earlier. ConClusions: The increasing role of HPV in SCCHN has had minimal impact on treatment paradigms, whereas the availability of new treatment options, such as IO, has significantly altered the course of the SCCHN patient journey.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.